drugset / Trial / NCT00383864

Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.

NCT00383864

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to evaluate the efficacy (and safety) of antiviral therapy in patients with chronic hepatitis C after liver transplantation. The only approved drugs for treatment of hepatitis C are pegylated interferon and ribavirin.

Timeline

Start
2001-07
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Peginterferon alfa-2b Protein / enzyme biologic
Subject Ribavirin Small molecule